US Jury Says Apple Must Pay Masimo $634 Million in Smartwatch Patent Case
The ITC reviews whether Apple Watch’s blood oxygen data display on the paired iPhone violates Masimo’s patent after a new feature redesign launched in August.
- In new filings today, the U.S. International Trade Commission instituted a combined modification and enforcement proceeding to review Apple's redesigned Blood Oxygen feature after a complaint from Masimo, health-technology company.
- After Masimo accused Apple of patent infringement, Apple paused sales and in August redesigned the Blood Oxygen feature for the Series 9, Series 10 and Ultra 2.
- You start a session using the Blood Oxygen feature on your Apple Watch and its sensors collect data, but results appear only in the Respiratory section of the iPhone Health app, raising paired watch+iPhone patent issues.
- The ITC says it expects to make a decision within six months in a proceeding that will address whether Apple's solution should be banned under the Masimo patent dispute, potentially extending the initial import ban.
- Amid a longstanding legal battle, a jury verdict for Masimo escalated the stakes as a California federal jury found Apple infringed Masimo's patent, while Apple plans to appeal and related suits include Masimo's challenge to US Customs and Border Protection.
37 Articles
37 Articles
Apple Loses Patent Lawsuit over Watch Blood Oxygen Measurement; Verdict: 900 Billion Won in Damages.
(San Francisco = Yonhap News) Correspondent Kwon Young-jeon = Apple's smartwatch, the Apple Watch, has been accused of infringing on a patent from medical technology company Masimo for its blood oxygen measurement function...
Apple under USITC investigation again over Apple Watch blood oxygen sensing
The USITC has started a new investigation looking at the Apple Watch, to see if the blood oxygenation sensing changes implemented earlier in 2025 still infringe patents held by medical tech company Masimo.Apple Watch Series 9 versus Apple Watch Ultra 2On Friday, the US International Trade Commission (ITC) issued an order to restart an investigation about Apple Watch, and the potential violation of Masimo's patents. This time, the investigation i…
The US International Trade Commission (ITC) decided this Friday to initiate a new procedure to determine whether Apple’s updated Apple Watch imports should be banned as part of a patent dispute with the medical monitoring technology company Masimo. ITC said in an order that it would investigate whether Apple Watch redesigned to circumvent an earlier import ban issued by the commission continues to violate Masimo’s patents covering oxygen-in-bloo…
American company was accused of violating rights in training mode of the device
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium













